Acrolein induces mitochondrial dysfunction and insulin resistance in muscle and adipose tissues in vitro and in vivo.

[1]  Qingli Wu,et al.  Acrolein: formation, health hazards and its controlling by dietary polyphenols. , 2023, Critical reviews in food science and nutrition.

[2]  L. Trasande,et al.  Endocrine disruptors in plastics alter β-cell physiology and increase the risk of diabetes mellitus , 2023, American journal of physiology. Endocrinology and metabolism.

[3]  S. Bungău,et al.  Novel Molecules in Diabetes Mellitus, Dyslipidemia and Cardiovascular Disease , 2023, International journal of molecular sciences.

[4]  G. Santulli,et al.  Tirzepatide: A Systematic Update , 2022, International journal of molecular sciences.

[5]  R. Gabbay,et al.  Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). , 2022, Diabetes care.

[6]  Chih-Ching Lin,et al.  Acrolein plays a culprit role in the pathogenesis of diabetic nephropathy in vitro and in vivo. , 2022, European journal of endocrinology.

[7]  A. Janež,et al.  Metformin and Insulin Resistance: A Review of the Underlying Mechanisms behind Changes in GLUT4-Mediated Glucose Transport , 2022, International journal of molecular sciences.

[8]  F. Ghorbani,et al.  The antioxidant roles of L-carnitine and N-acetyl cysteine against oxidative stress on human sperm functional parameters during vitrification , 2021, Clinical and experimental reproductive medicine.

[9]  Shing-Hwa Liu,et al.  Low-Dose Acrolein, an Endogenous and Exogenous Toxic Molecule, Inhibits Glucose Transport via an Inhibition of Akt-Regulated GLUT4 Signaling in Skeletal Muscle Cells , 2021, International journal of molecular sciences.

[10]  Hao Yang,et al.  Association Between Different Obesity Patterns and the Risk of Developing Type 2 Diabetes Mellitus Among Adults in Eastern China: A Cross-Sectional Study , 2021, Diabetes, metabolic syndrome and obesity : targets and therapy.

[11]  O. Shirihai,et al.  Isolation and functional analysis of peridroplet mitochondria from murine brown adipose tissue , 2020, STAR protocols.

[12]  César Martín,et al.  Pathophysiology of Type 2 Diabetes Mellitus , 2020, International journal of molecular sciences.

[13]  C. Dass,et al.  C2C12 cell model: its role in understanding of insulin resistance at the molecular level and pharmaceutical development at the preclinical stage , 2020, The Journal of pharmacy and pharmacology.

[14]  B. Jiang,et al.  Arsenic exposure-related hyperglycemia is linked to insulin resistance with concomitant reduction of skeletal muscle mass. , 2020, Environment international.

[15]  J. Muntané,et al.  Mechanisms of action of metformin in type 2 diabetes: Effects on mitochondria and leukocyte-endothelium interactions , 2020, Redox biology.

[16]  S. Bungău,et al.  Risk factors for adiposity in the urban population and influence on the prevalence of overweight and obesity. , 2020, Experimental and therapeutic medicine.

[17]  J. Muntané,et al.  Mitochondria and T2D: Role of Autophagy, ER Stress, and Inflammasome , 2020, Trends in Endocrinology & Metabolism.

[18]  M. Coghlan,et al.  How May GIP Enhance the Therapeutic Efficacy of GLP-1? , 2020, Trends in Endocrinology & Metabolism.

[19]  S. Maiti,et al.  Chronic Tobacco Exposure by Smoking develops Insulin Resistance. , 2020, Endocrine, metabolic & immune disorders drug targets.

[20]  G. Shulman,et al.  The integrative biology of type 2 diabetes , 2019, Nature.

[21]  M. Farzaei,et al.  Targeting AMPK signaling pathway by natural products for treatment of diabetes mellitus and its complications , 2019, Journal of cellular physiology.

[22]  Kyoung-Jin Oh,et al.  The Role of Adipose Tissue Mitochondria: Regulation of Mitochondrial Function for the Treatment of Metabolic Diseases , 2019, International journal of molecular sciences.

[23]  L. Heilbronn,et al.  Mitochondrial (Dys)function and Insulin Resistance: From Pathophysiological Molecular Mechanisms to the Impact of Diet , 2019, Front. Physiol..

[24]  Y. Yoo,et al.  Persistent Organic Pollutant-Mediated Insulin Resistance , 2019, International journal of environmental research and public health.

[25]  Farzane Sivandzade,et al.  Analysis of the Mitochondrial Membrane Potential Using the Cationic JC-1 Dye as a Sensitive Fluorescent Probe. , 2019, Bio-protocol.

[26]  W. Teng,et al.  Association between air pollution and type 2 diabetes: an updated review of the literature , 2019, Therapeutic advances in endocrinology and metabolism.

[27]  J. Moore,et al.  Associations of Exposure to Air Pollution with Insulin Resistance: A Systematic Review and Meta-Analysis , 2018, International journal of environmental research and public health.

[28]  B. Kahn,et al.  Metabolites as regulators of insulin sensitivity and metabolism , 2018, Nature Reviews Molecular Cell Biology.

[29]  P. Jarosz-Chobot,et al.  Obesity and diabetes—Not only a simple link between two epidemics , 2018, Diabetes/metabolism research and reviews.

[30]  R. Mahmood,et al.  Carnosine and N‐acetyl cysteine protect against sodium nitrite‐induced oxidative stress in rat blood , 2018, Cell biology international.

[31]  T. Heck,et al.  Fine Particulate Matter (PM2.5) Air Pollution and Type 2 Diabetes Mellitus (T2DM): When Experimental Data Explains Epidemiological Facts , 2017 .

[32]  Huadong Liu,et al.  Akt activation: A potential strategy to ameliorate insulin resistance. , 2017, Diabetes research and clinical practice.

[33]  Wei Zhang,et al.  Acrolein Scavenger Hydralazine Prevents Streptozotocin‐Induced Painful Diabetic Neuropathy and Spinal Neuroinflammation in Rats , 2017, Anatomical record.

[34]  K. Khunti,et al.  Type 2 diabetes , 2017, The Lancet.

[35]  Xiaojun Ma,et al.  Suppression of Ghrelin Exacerbates HFCS-Induced Adiposity and Insulin Resistance , 2017, International journal of molecular sciences.

[36]  Y. Yoo,et al.  Polychlorinated biphenyls exposure-induced insulin resistance is mediated by lipid droplet enlargement through Fsp27 , 2017, Archives of Toxicology.

[37]  L. Trasande,et al.  Exposure to Bisphenols and Phthalates and Association with Oxidant Stress, InsulinN Resistance, and Endothelial Dysfunction in Children , 2017, Pediatric Research.

[38]  N. Câmara,et al.  Diabetes and increased lipid peroxidation are associated with systemic inflammation even in well-controlled patients. , 2016, Journal of diabetes and its complications.

[39]  M. Wong,et al.  Mouse Models of Diabetes, Obesity and Related Kidney Disease , 2016, PloS one.

[40]  F. Scinicariello,et al.  Acrolein metabolites, diabetes and insulin resistance. , 2016, Environmental research.

[41]  Zhuo Zhang,et al.  Arsenic Induces Insulin Resistance in Mouse Adipocytes and Myotubes Via Oxidative Stress-Regulated Mitochondrial Sirt3-FOXO3a Signaling Pathway. , 2015, Toxicological sciences : an official journal of the Society of Toxicology.

[42]  C. McClain,et al.  Molecular mechanisms of acrolein toxicity: relevance to human disease. , 2015, Toxicological sciences : an official journal of the Society of Toxicology.

[43]  N. Cooper,et al.  Acrolein decreases endothelial cell migration and insulin sensitivity through induction of let-7a. , 2014, Toxicological sciences : an official journal of the Society of Toxicology.

[44]  Stephen L. Pinkosky,et al.  AMP-activated protein kinase: an emerging drug target to regulate imbalances in lipid and carbohydrate metabolism to treat cardio-metabolic diseases , 2012, Journal of Lipid Research.

[45]  Jeffery Grigsby,et al.  A Possible Role of Acrolein in Diabetic Retinopathy: Involvement of a VEGF/TGFβ Signaling Pathway of the Retinal Pigment Epithelium in Hyperglycemia , 2012, Current eye research.

[46]  M. Tang,et al.  Effect of Carcinogenic Acrolein on DNA Repair and Mutagenic Susceptibility* , 2012, The Journal of Biological Chemistry.

[47]  E. Gilbert,et al.  Development of a Nongenetic Mouse Model of Type 2 Diabetes , 2011, Experimental diabetes research.

[48]  Zheng Sun,et al.  Acrolein scavengers: reactivity, mechanism and impact on health. , 2011, Molecular nutrition & food research.

[49]  F. Andrade,et al.  Mitochondrial isolation from skeletal muscle. , 2011, Journal of visualized experiments : JoVE.

[50]  P. Deedwania.  Hypertension, Dyslipidemia, and Insulin Resistance in Patients With Diabetes Mellitus or the Cardiometabolic Syndrome: Benefits of Vasodilating β‐Blockers , 2011, Journal of clinical hypertension.

[51]  K. Petersen,et al.  Lipid-induced insulin resistance: unravelling the mechanism , 2010, The Lancet.

[52]  P. Schrauwen,et al.  Prolonged Fasting Identifies Skeletal Muscle Mitochondrial Dysfunction as Consequence Rather Than Cause of Human Insulin Resistance , 2010, Diabetes.

[53]  P. Puigserver,et al.  Foxo1 integrates insulin signaling with mitochondrial function in the liver , 2009, Nature Medicine.

[54]  M. Funaki.  Saturated fatty acids and insulin resistance. , 2009, The journal of medical investigation : JMI.

[55]  P. Neufer,et al.  Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. , 2009, The Journal of clinical investigation.

[56]  L. Heilbronn,et al.  Is mitochondrial dysfunction a cause of insulin resistance? , 2008, Trends in Endocrinology & Metabolism.

[57]  Joris Hoeks,et al.  Lower Intrinsic ADP-Stimulated Mitochondrial Respiration Underlies In Vivo Mitochondrial Dysfunction in Muscle of Male Type 2 Diabetic Patients , 2008, Diabetes.

[58]  Dong-Ho Han,et al.  High-fat diets cause insulin resistance despite an increase in muscle mitochondria , 2008, Proceedings of the National Academy of Sciences.

[59]  F. Paccaud,et al.  Consequences of smoking for body weight, body fat distribution, and insulin resistance. , 2008, The American journal of clinical nutrition.

[60]  P. Schrauwen,et al.  Mitochondrial function, content and ROS production in rat skeletal muscle: Effect of high‐fat feeding , 2008, FEBS letters.

[61]  E. Mariman,et al.  Short-term high fat-feeding results in morphological and metabolic adaptations in the skeletal muscle of C57BL/6J mice. , 2008, Physiological genomics.

[62]  N. Turner,et al.  Excess Lipid Availability Increases Mitochondrial Fatty Acid Oxidative Capacity in Muscle , 2007, Diabetes.

[63]  K. Petersen,et al.  Disordered lipid metabolism and the pathogenesis of insulin resistance. , 2007, Physiological reviews.

[64]  Mark A Pereira,et al.  Trans fatty acids, insulin resistance, and type 2 diabetes. , 2006, Nutrition reviews.

[65]  M. Febbraio,et al.  Saturated, but not n-6 polyunsaturated, fatty acids induce insulin resistance: role of intramuscular accumulation of lipid metabolites. , 2006, Journal of applied physiology.

[66]  U. Risérus.  Trans fatty acids and insulin resistance. , 2006, Atherosclerosis. Supplements.

[67]  Z. Shen,et al.  2-NBDG as a fluorescent indicator for direct glucose uptake measurement. , 2005, Journal of biochemical and biophysical methods.

[68]  K. Adeli,et al.  Nutrition & Metabolism BioMed Central Review , 2005 .

[69]  B. Lowell,et al.  Mitochondrial Dysfunction and Type 2 Diabetes , 2005, Science.

[70]  P. Boor,et al.  Glutathione-S-transferase A4-4 modulates oxidative stress in endothelium: possible role in human atherosclerosis. , 2004, Atherosclerosis.

[71]  M. Díaz-Flores,et al.  Glucose-stimulated acrolein production from unsaturated fatty acids , 2004, Human & experimental toxicology.

[72]  H. Tsukahara,et al.  Formation of Advanced Glycosylation End Products and Oxidative Stress in Young Patients with Type 1 Diabetes , 2003, Pediatric Research.

[73]  M. Daly,et al.  PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.

[74]  A. Butte,et al.  Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[75]  K. Nair,et al.  Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[76]  K. Kashiwagi,et al.  Increase in putrescine, amine oxidase, and acrolein in plasma of renal failure patients. , 2003, Biochemical and biophysical research communications.

[77]  Douglas L. Rothman,et al.  Mitochondrial Dysfunction in the Elderly: Possible Role in Insulin Resistance , 2003, Science.

[78]  Takeo Kato,et al.  Increased urinary levels of pentosidine, pyrraline and acrolein adduct in type 2 diabetes. , 2003, Endocrine journal.

[79]  Jing He,et al.  Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. , 2002, Diabetes.

[80]  B. Goldstein.  Insulin resistance as the core defect in type 2 diabetes mellitus. , 2002, The American journal of cardiology.

[81]  Margaret S. Wu,et al.  Role of AMP-activated protein kinase in mechanism of metformin action. , 2001, The Journal of clinical investigation.

[82]  G. Dohm,et al.  Lipid oxidation is reduced in obese human skeletal muscle. , 2000, American journal of physiology. Endocrinology and metabolism.

[83]  Rena R Wing,et al.  Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. , 1999, American journal of physiology. Endocrinology and metabolism.

[84]  J. Simoneau,et al.  Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[85]  T. Miyata,et al.  Carbonyl stress in the pathogenesis of diabetic nephropathy. , 1999, Internal medicine.

[86]  P. Boor,et al.  The role of glutathione S-transferases as a defense against reactive electrophiles in the blood vessel wall. , 1998, Toxicology and applied pharmacology.

[87]  E. Niki,et al.  Acrolein Is a Product of Lipid Peroxidation Reaction , 1998, The Journal of Biological Chemistry.

[88]  M. Williams,et al.  Development of Insulin Resistance in 3T3-L1 Adipocytes* , 1997, The Journal of Biological Chemistry.

[89]  V. P. Knutson,et al.  3T3-L1 adipocytes as a cell culture model of insulin resistance , 1997, In Vitro Cellular & Developmental Biology - Animal.

[90]  D. James,et al.  Insulin-regulatable tissues express a unique insulin-sensitive glucose transport protein , 1988, Nature.

[91]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[92]  Manjeet Singh,et al.  Role of by-products of lipid oxidation in Alzheimer's disease brain: a focus on acrolein. , 2010, Journal of Alzheimer's disease : JAD.

[93]  T. Uzu,et al.  Structural and functional changes in the kidneys of high-fat diet-induced obese mice. , 2009, American journal of physiology. Renal physiology.

[94]  J. Holloszy.  Skeletal muscle "mitochondrial deficiency" does not mediate insulin resistance. , 2009, The American journal of clinical nutrition.

[95]  J. F. Stevens,et al.  Acrolein: sources, metabolism, and biomolecular interactions relevant to human health and disease. , 2008, Molecular nutrition & food research.

[96]  J. Sowers,et al.  Role of Mitochondrial Dysfunction in Insulin Resistance , 2008 .

[97]  R. Crescenzo,et al.  Skeletal muscle oxidative capacity in rats fed high-fat diet , 2002, International Journal of Obesity.

[98]  R. Tjeerdema,et al.  Fate and effects of acrolein. , 1995, Reviews of environmental contamination and toxicology.